BMO Upgrades HealthEquity to Outperform Amid Growth Optimism
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Apr 09 2026
0mins
Source: seekingalpha
- Rating Upgrade: BMO Capital Markets upgraded HealthEquity's rating from Market Perform to Outperform, with analyst Sean Dodge highlighting that fears related to AI are overblown, suggesting the current stock price offers a compelling entry point for investors.
- Increased Growth Expectations: Dodge raised HealthEquity's long-term growth estimates from mid-single digits/high single digits to high single digits/low double digits, indicating that the recent launch of the Marketplace business will create additional monetization opportunities for its member base, further driving revenue growth.
- Price Target Increase: BMO raised HealthEquity's price target from $85 to $105 per share, reflecting confidence in the company's future performance and anticipating benefits from the successful implementation of its Marketplace business.
- Strong Financial Performance: HealthEquity's recent non-GAAP EPS of $0.95 exceeded expectations by $0.05, while revenue of $334.6 million surpassed estimates by $1.78 million, indicating ongoing improvements in the company's financial health.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy HQY?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on HQY
Wall Street analysts forecast HQY stock price to rise
11 Analyst Rating
9 Buy
1 Hold
1 Sell
Moderate Buy
Current: 86.330
Low
89.00
Averages
117.09
High
129.00
Current: 86.330
Low
89.00
Averages
117.09
High
129.00
About HQY
HealthEquity, Inc. is engaged in providing technology-enabled services that enables consumers to make healthcare saving and spending decisions. The Company uses its technology to manage consumer tax-advantaged health savings accounts (HSAs) and other consumer-directed benefits (CDBs) offered by employers, including flexible spending accounts and health reimbursement arrangements (FSAs and HRAs), and to administer Consolidated Omnibus Budget Reconciliation Act (COBRA), commuter and other benefits. It provides consumers with payment processing services, personalized benefit information, the ability to earn wellness incentives, and investment advice. It offers an investment platform and access to an online-only automated investment advisory service to all of its members whose account balances exceed a stated threshold. It administers pre-tax commuter benefit programs through which employers are permitted to provide employees with commuter benefits including qualified transit and parking.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
Healthcare Affordability Pressure Intensifies for American Workers
- Healthcare Cost Impact: Over one-third of American workers are delaying or avoiding care due to costs, highlighting the significant impact of healthcare expenses on household finances and workplace productivity, particularly among low-income and younger worker demographics.
- Consequences of Delayed Care: Among the 36% of respondents who delayed care, 44% were chronic condition patients, indicating that such delays can lead to worsened health outcomes and further increase the economic burden on the healthcare system, exceeding $5 billion annually.
- Financial Stress and Productivity: Nearly half of respondents report increased financial worries, with younger workers being four times more likely than older generations to be distracted at work due to financial strain, resulting in an average loss of 7.3 hours of productivity per week, costing employers approximately $183 billion annually.
- Positive Impact of HSAs: Individuals with Health Savings Accounts (HSAs) demonstrate significantly better affordability and financial preparedness regarding healthcare expenses, with 88% feeling more financially secure due to their HSA, underscoring the importance of HSAs in improving the healthcare cost experience.
See More
HealthEquity Reports Strong Q1 Growth with Raised Guidance
- Profitability Improvement: HealthEquity's first-quarter adjusted EBITDA margin increased to 46%, with net income reaching $69.4 million, demonstrating strong execution of the company's financial model, which is expected to drive stock price appreciation and enhance investor confidence.
- Expanded Share Buyback Plan: The company's board increased the share repurchase authorization by $1 billion, indicating management's confidence in the company's value, which is anticipated to further boost earnings per share and enhance shareholder returns.
- Significant HSA Asset Growth: Total HSA assets grew by 19% year-over-year, with 172,000 new HSAs added, reflecting a 15% growth rate, which not only increases market share but also enhances customer loyalty, driving future revenue growth.
- Optimistic Financial Outlook: The company raised its fiscal 2027 revenue guidance to between $1.41 billion and $1.42 billion, with GAAP EPS expectations increased to $2.88 to $2.95, indicating strong market demand and ongoing improvements in profitability.
See More
HealthEquity Reports Significant Revenue Growth
- Revenue Growth: HealthEquity reported a 7% year-over-year revenue increase in Q1, with service revenue hitting a record $122.9 million, up 3%, indicating strong market performance and sustained customer demand.
- Profitability Improvement: Adjusted EBITDA reached $164.5 million, representing 46% of revenue and a 17% increase from last year, demonstrating significant progress in cost control and operational efficiency, thereby enhancing future profitability sustainability.
- Share Repurchase Plan: The company increased its share repurchase authorization by $1 billion, reflecting strong confidence in capital allocation and management's optimistic outlook on the company's growth potential.
- HSA Asset Growth: Total HSA assets grew by 19%, with new HSAs from sales increasing by 15%, not only enhancing the company's market share but also laying a foundation for future revenue growth, showcasing its competitive advantage in the health savings account sector.
See More
HealthEquity (HQY) Q1 2027 Earnings Transcript
See More
HealthEquity Q1 Earnings Exceed Expectations
- Earnings Beat: HealthEquity reported a Q1 non-GAAP EPS of $1.24, exceeding expectations by $0.12, which reflects the company's strong profitability growth and enhances market confidence in its future performance.
- Revenue Growth: Q1 revenue reached $354.6 million, a 7.2% year-over-year increase, surpassing market expectations by $2.3 million, indicating sustained demand in the health benefits management sector and driving robust overall business development.
- Financial Outlook: Management expects revenues for the fiscal year ending January 31, 2027, to be between $1.410 billion and $1.420 billion, aligning with market consensus, which demonstrates the company's stable revenue expectations and helps attract investor interest.
- Net Income Projections: The anticipated net income is between $242 million and $248 million, resulting in diluted earnings per share of $2.88 to $2.95, with non-GAAP net income projected at $392 million to $398 million, further solidifying the company's strong financial health image.
See More
HealthEquity Set to Announce Q1 Earnings on May 28
- Earnings Announcement: HealthEquity (HQY) is scheduled to release its Q1 2023 earnings on May 28 after market close, with consensus EPS estimates at $1.11, reflecting a 14.4% year-over-year growth, indicating ongoing improvement in profitability.
- Revenue Expectations: Analysts project HQY's revenue to reach $352.17 million, representing a 6.4% year-over-year increase, which underscores the company's robust performance in the healthcare insurance market and expansion of its customer base.
- Historical Performance: Over the past two years, HQY has exceeded EPS estimates 88% of the time and revenue estimates 100% of the time, showcasing the company's strong capabilities in market analysis and performance delivery.
- Estimate Revision Dynamics: In the last three months, EPS estimates have seen three upward revisions and five downward adjustments, while revenue estimates experienced five upward revisions and two downward adjustments, reflecting varying market perceptions regarding the company's future performance.
See More
Healthcare Affordability Pressure Intensifies for American Workers
- Healthcare Cost Impact: Over one-third of American workers are delaying or avoiding care due to costs, highlighting the significant impact of healthcare expenses on household finances and workplace productivity, particularly among low-income and younger worker demographics.
- Consequences of Delayed Care: Among the 36% of respondents who delayed care, 44% were chronic condition patients, indicating that such delays can lead to worsened health outcomes and further increase the economic burden on the healthcare system, exceeding $5 billion annually.
- Financial Stress and Productivity: Nearly half of respondents report increased financial worries, with younger workers being four times more likely than older generations to be distracted at work due to financial strain, resulting in an average loss of 7.3 hours of productivity per week, costing employers approximately $183 billion annually.
- Positive Impact of HSAs: Individuals with Health Savings Accounts (HSAs) demonstrate significantly better affordability and financial preparedness regarding healthcare expenses, with 88% feeling more financially secure due to their HSA, underscoring the importance of HSAs in improving the healthcare cost experience.
See More
HealthEquity Reports Strong Q1 Growth with Raised Guidance
- Profitability Improvement: HealthEquity's first-quarter adjusted EBITDA margin increased to 46%, with net income reaching $69.4 million, demonstrating strong execution of the company's financial model, which is expected to drive stock price appreciation and enhance investor confidence.
- Expanded Share Buyback Plan: The company's board increased the share repurchase authorization by $1 billion, indicating management's confidence in the company's value, which is anticipated to further boost earnings per share and enhance shareholder returns.
- Significant HSA Asset Growth: Total HSA assets grew by 19% year-over-year, with 172,000 new HSAs added, reflecting a 15% growth rate, which not only increases market share but also enhances customer loyalty, driving future revenue growth.
- Optimistic Financial Outlook: The company raised its fiscal 2027 revenue guidance to between $1.41 billion and $1.42 billion, with GAAP EPS expectations increased to $2.88 to $2.95, indicating strong market demand and ongoing improvements in profitability.
See More
HealthEquity Reports Significant Revenue Growth
- Revenue Growth: HealthEquity reported a 7% year-over-year revenue increase in Q1, with service revenue hitting a record $122.9 million, up 3%, indicating strong market performance and sustained customer demand.
- Profitability Improvement: Adjusted EBITDA reached $164.5 million, representing 46% of revenue and a 17% increase from last year, demonstrating significant progress in cost control and operational efficiency, thereby enhancing future profitability sustainability.
- Share Repurchase Plan: The company increased its share repurchase authorization by $1 billion, reflecting strong confidence in capital allocation and management's optimistic outlook on the company's growth potential.
- HSA Asset Growth: Total HSA assets grew by 19%, with new HSAs from sales increasing by 15%, not only enhancing the company's market share but also laying a foundation for future revenue growth, showcasing its competitive advantage in the health savings account sector.
See More
HealthEquity (HQY) Q1 2027 Earnings Transcript
See More
HealthEquity Q1 Earnings Exceed Expectations
- Earnings Beat: HealthEquity reported a Q1 non-GAAP EPS of $1.24, exceeding expectations by $0.12, which reflects the company's strong profitability growth and enhances market confidence in its future performance.
- Revenue Growth: Q1 revenue reached $354.6 million, a 7.2% year-over-year increase, surpassing market expectations by $2.3 million, indicating sustained demand in the health benefits management sector and driving robust overall business development.
- Financial Outlook: Management expects revenues for the fiscal year ending January 31, 2027, to be between $1.410 billion and $1.420 billion, aligning with market consensus, which demonstrates the company's stable revenue expectations and helps attract investor interest.
- Net Income Projections: The anticipated net income is between $242 million and $248 million, resulting in diluted earnings per share of $2.88 to $2.95, with non-GAAP net income projected at $392 million to $398 million, further solidifying the company's strong financial health image.
See More
HealthEquity Set to Announce Q1 Earnings on May 28
- Earnings Announcement: HealthEquity (HQY) is scheduled to release its Q1 2023 earnings on May 28 after market close, with consensus EPS estimates at $1.11, reflecting a 14.4% year-over-year growth, indicating ongoing improvement in profitability.
- Revenue Expectations: Analysts project HQY's revenue to reach $352.17 million, representing a 6.4% year-over-year increase, which underscores the company's robust performance in the healthcare insurance market and expansion of its customer base.
- Historical Performance: Over the past two years, HQY has exceeded EPS estimates 88% of the time and revenue estimates 100% of the time, showcasing the company's strong capabilities in market analysis and performance delivery.
- Estimate Revision Dynamics: In the last three months, EPS estimates have seen three upward revisions and five downward adjustments, while revenue estimates experienced five upward revisions and two downward adjustments, reflecting varying market perceptions regarding the company's future performance.
See More
